Discontinued — last reported Q3 '23
Wells Fargo & Company Interest Paid increased by 1.5% to $10.11B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.0%, from $10.53B to $10.11B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 73.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.25B | $1.06B | $977.00M | $661.00M | $1.58B | $2.02B | $4.03B | $5.48B | $7.37B | $8.03B | $9.55B | $10.39B | $11.17B | $11.54B | $10.53B | $9.79B | $9.94B | $9.97B | $10.11B |
| QoQ Change | — | -15.3% | -8.0% | -32.3% | +138.9% | +28.2% | +98.9% | +36.1% | +34.6% | +9.0% | +18.9% | +8.8% | +7.5% | +3.3% | -8.7% | -7.0% | +1.5% | +0.3% | +1.5% |
| YoY Change | — | — | — | — | +25.9% | +90.6% | +312.0% | +728.6% | +366.8% | +296.9% | +137.2% | +89.6% | +51.5% | +43.6% | +10.3% | -5.7% | -11.0% | -13.6% | -4.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.